Andere talen North China Pharmaceutical Company.Ltd

Aandelen

600812

CNE000000D16

slotkoers Shanghai S.E. Andere beurzen 00:00:00 08-05-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
5,31 ^CNY	+0,76%		+2,51%	-6,84%

25/04	North China Pharmaceutical Company.Ltd rapporteert resultaten voor het eerste kwartaal dat eindigde op 31 maart 2024	CI
29/03	North China Pharmaceutical Company.Ltd rapporteert resultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

North China Pharmaceutical Company.Ltd Reports Earnings Results for the First Quarter Ended March 31, 2024	25/04
North China Pharmaceutical Company.Ltd agreed to acquire the remaining 35.85% stake in NCPC Hebei Huamin Pharmaceutical Co., Ltd. from CCB Financial Asset Investment Co., Ltd. for CNY 670 million	30/03
North China Pharmaceutical Company.Ltd Reports Earnings Results for the Full Year Ended December 31, 2023	29/03
North China Pharmaceutical Subsidiary Gets Europe's Compliance Certification for Drug Raw Material	27/02
Jizhong Energy Group Finance Co., Ltd announced that it has received CNY 1.3 billion in funding from Jizhong Energy Group Co.,Ltd., Jizhong Energy Resources Co., Ltd., North China Pharmaceutical Company.Ltd	06/12
North China Pharmaceutical Gets Nod to Market Ampicillin API	20/11
North China Pharmaceutical Company.Ltd Reports Earnings Results for the Nine Months Ended September 30, 2023	26-10-23
North China Pharmaceutical Company.Ltd(XSSC:600812) added to S&P Global BMI Index	18-09-23
North China Pharmaceutical Company.Ltd(XSSC:600812) added to FTSE All-World Index	18-09-23
North China Pharmaceutical Company.Ltd Reports Earnings Results for the Half Year Ended June 30, 2023	18-08-23
Jizhong Energy Group Finance Co., Ltd announced that it expects to receive CNY 1.3 billion in funding from Jizhong Energy Group Co.,Ltd., Jizhong Energy Resources Co., Ltd., North China Pharmaceutical Company.Ltd	17-08-23
North China Pharmaceutical Company Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	26-04-23
North China Pharma Unit Passes Compliance Inspection	31-03-23
North China Pharmaceutical's Heart Drug Passes Regulatory Evaluation	13-02-23
North China Pharmaceutical Company Ltd.(SHSE:600812) dropped from Shanghai Stock Exchange Health Care Sector Index	09-12-22
North China Pharmaceutical Company Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2022	26-10-22
North China Pharmaceutical Company Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2022	28-04-22
North China Pharmaceutical Company Ltd. Reports Earnings Results for the Full Year Ended December 31, 2021	28-04-22
China Rolls Out New Rules to Fight Monopoly in API Drugmaking Market	19-11-21
North China Pharmaceutical Company Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2021	22-10-21

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen North China Pharmaceutical Company.Ltd

Aandelen

600812

CNE000000D16

Andere talen

Filters